3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Endometrial Neoplasms
6
Lymphatic Metastasis
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Clinical Stage I Gastric Cancer AJCC v8
2
Carcinoma, Transitional Cell
2
Vulvar Neoplasms
1
Urologic Neoplasms
1
Ureteral Neoplasms
1
Recurrence
1
Radiation Injuries
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Ovarian Neoplasms
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Mixed Tumor, Mesodermal
1
Melanoma
1
Lymphedema
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Disease
1
Cholangiocarcinoma
1
Interventions
Magnetic Resonance Spectroscopy
6
Dexamethasone
6
Cyclophosphamide
6
Blood Specimen Collection
6
Prednisone
5
Positron Emission Tomography Computed Tomography
4
Mammography
4
Lenalidomide
4
Colonoscopy
4
pembrolizumab
3
Tomography, X-Ray Computed
3
Surveys and Questionnaires
3
Melphalan
3
Exercise
3
Biopsy
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
weifuchun
2
obinutuzumab
2
fluciclovine F-18
2
daratumumab
2
carfilzomib
2
Preoperative Exercise
2
Positron-Emission Tomography
2
Methods
2
Magnetic Resonance Imaging
2
Injections
2
Gemcitabine
2
Educational Status
2
Doxorubicin
2
Cytarabine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Disease
×
Lymph Node Excision
×
Clear all
NCT02951897
2016-11-02
CTCs detection
Third Military Medical University
Phase NA
Unknown
120 enrolled